Identification of sulfonylpyrimidines as novel selective aldosterone synthase (CYP11B2) inhibitors

被引：1

作者：

Meguro, Masaki ^{[1
]}

Miyauchi, Satoru ^{[2
]}

Kanao-Arisumi, Yukiko ^{[3
]}

Naito, Satoru ^{[4
]}

Suzuki, Kanae ^{[1
]}

Inoue, Shinichi ^{[5
]}

Yamada, Keisuke ^{[6
]}

Homma, Tsuyoshi ^{[1
]}

Chiba, Kiyoshi ^{[1
]}

Nara, Futoshi ^{[7
]}

Furuzono, Shinji ^{[1
]}

机构：

[1] Daiichi Sankyo Co Ltd, Shinagawa R&D Ctr, 1-2-58 Hiromachi,Shinagawa Ku, Tokyo 1408710, Japan

[2] Daiichi Sankyo Co Ltd, Technol Div, Technol Business Management Grp, 1-12-1 Shinomiya, Hiratsuka, Kanagawa 2540014, Japan

[3] Pharmaun Co Ltd, 1-23-39 Hiikawa,Jounan Ku, Fukuoka, Fukuoka 8140153, Japan

[4] Daiichi Sankyo Business Associe Co Ltd, Site Operat Dept, Shinagawa Site Operat Grp, 1-2-58 Hiromachi,Shinagawa Ku, Tokyo 1408710, Japan

[5] Daiichi Sankyo Inc, 211 Mt Airy Rd, Basking Ridge, NJ 07920 USA

[6] Daiichi Sankyo Co Ltd, Med Affairs Div, Med Affairs Planning Dept, 3-5-1 Nihonbashi Honcho,Chuo Ku, Tokyo 1038426, Japan

[7] Shin Nippon Biomed Labs Ltd, 8-1-28 Akashicho,Chuo Ku, Tokyo 1040044, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2024年 / 108卷

关键词：

Aldosterone; Aldosterone synthase inhibitor; Sulfone; Amino-pyrimidine; IN-VIVO ACTIVITY; POTENTIAL TREATMENTS; DISCOVERY; LCI699; THIOLS;

D O I：

10.1016/j.bmc.2024.117775

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

4-[(5-[2-Methyl-5-(methylsulfonyl)pentan-2-yl]sulfonylpyrimidin-4-yl)amino]benzonitrile 2 was identified as a novel potent aldosterone synthase inhibitor. Compound 2 was found to inhibit human CYP11B2 in the nanomolar range, and showed an aldosterone-lowering effect in a furosemide-treated cynomolgus monkey model. Although human CYP11B2 has the high homology sequence with human CYP11B1, compound 2 showed more than 80 times higher selectivity over human CYP11B1 in vitro.

引用

页数：15

共 50 条

[11] Discovery of selective CYP11B2 (aldosterone synthase) inhibitors for the therapy of congestive heart failure and myocardial fibrosis
Hartmann, RW
Mülller, U
Ehmer, PB
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2003, 38 (04) : 363 - 366
[12] Discovery of indazole aldosterone synthase (CYP11B2) inhibitors as potential treatments for hypertension
Hoyt, Scott B.
Taylor, Jerry
London, Clare
Ali, Amjad
Ujjainwalla, Feroze
Tata, Jim
Struthers, Mary
Cully, Doris
Wisniewski, Tom
Ren, Ning
Bopp, Charlene
Sok, Andrea
Verras, Andreas
McMasters, Daniel
Chen, Qing
Tung, Elaine
Tang, Wei
Salituro, Gino
Clemas, Joe
Zhou, Gaochao
MacNeil, Douglas
Duffy, Ruth
Xiong, Yusheng
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (11) : 2384 - 2388
[13] Aldosterone synthase (CYP11B2) polymorphisms and cardiovascular function
White, PC
Hautanen, A
Kupari, M
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1999, 69 (1-6): : 409 - 412
[14] Aldosterone synthase (CYP11B2) polymorphisms and cardiovascular function
White, PC
Hautanen, A
Kupari, M
ENDOCRINE RESEARCH, 1998, 24 (3-4) : 797 - 804
[15] Discovery and in Vivo Evaluation of Potent Dual CYP11B2 (Aldosterone Synthase) and CYP11B1 Inhibitors
Meredith, Erik L.
Ksander, Gary
Monovich, Lauren G.
Papillon, Julien P. N.
Liu, Qian
Miranda, Karl
Morris, Patrick
Rao, Chang
Burgis, Robin
Capparelli, Michael
Hu, Qi-Ying
Singh, Alok
Rigel, Dean F.
Jeng, Arco Y.
Beil, Michael
Fu, Fumin
Hu, Chii-Whei
LaSala, Daniel
ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (12): : 1203 - 1207
[16] 4-Anilino-pyrimidine, novel aldosterone synthase (CYP11B2) inhibitors bearing pyrimidine structures
Meguro, Masaki
Miyauchi, Satoru
Kanao, Yukiko
Naito, Satoru
Suzuki, Kanae
Inoue, Shinichi
Yamada, Keisuke
Homma, Tsuyoshi
Chiba, Kiyoshi
Nara, Futoshi
Furuzono, Shinji
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (09) : 1902 - 1906
[17] A Novel CYP11B2 Gene Mutation in an Asian Family with Aldosterone Synthase Deficiency
Lovas, Kristian
McFarlane, Ian
Nguyen, Huy-Hoang
Curran, Suzanne
Schwabe, John
Halsall, David
Bernhardt, Rita
Wallace, A. Michael
Chatterjee, V. Krishna K.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (03): : 914 - 919
[18] N-(Pyridin-3-yl)benzamides as selective inhibitors of human aldosterone synthase (CYP11B2)
Zimmer, Christina
Hafner, Marieke
Zender, Michael
Ammann, Dominic
Hartmann, Rolf W.
Vock, Carsten A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (01) : 186 - 190
[19] Expression of aldosterone synthase CYP11B2 was inversely correlated with longevity
Hayashi, Taiki
Zhang, Zhen
Al-Eyd, Ghaith
Sasaki, Atsushi
Yasuda, Masanori
Oyama, Masafumi
Gomez-Sanchez, Celso E.
Asakura, Hirotaka
Seki, Tsugio
Mukai, Kuniaki
Nishimoto, Koshiro
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2019, 191
[20] The clinical significance of aldosterone synthase deficiency: report of a novel mutation in the CYP11B2 gene
Elaine Hui
Matthew CW Yeung
Pik To Cheung
Elaine Kwan
Louis Low
Kathryn CB Tan
Karen SL Lam
Angel OK Chan
BMC Endocrine Disorders, 14

← 1 2 3 4 5 →